Cutimed Acute Hydro-Cremeschaum 5% Urea, 125 ml SCH

Cutimed Acute Hydro-Cremeschaum 5% Urea, 125 ml SCH

Marsoni

M251S

$20.85

Get it in 3 business days with 1 day shipping. Friday, May 29

Cutimed Acute Hydro-Cremeschaum 5% Urea, 125 ml SCHbersicht Details Inhalt Hersteller: BSN medical GmbH (Originalprodukt aus Deutschland) PZN: 07250361 PZN: 7250361 Produkteigenschaften: Cutimed Acute Umweltfaktoren wie Klte oder Wrme, unzureichende Flssigkeitsaufnahme, aber auch therapeutische Manahmen knnen zu einem gesteigerten Feuchtigkeitsverlust der Haut fhren. Unangenehme Folge des Verlustes ist eine trockene, schuppige oder rissige Haut, die jucken und sich entznden kann. Ziel einer Behandlung

Easy Shipping

Quick Dispatch:

Your Cutimed Acute Hydro-Cremeschaum 5% Urea, 125 ml SCH orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Cutimed Acute Hydro-Cremeschaum 5% Urea, 125 ml SCH ships.

Need Help?
Questions about Cutimed Acute Hydro-Cremeschaum 5% Urea, 125 ml SCH, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Cutimed Acute Hydro-Cremeschaum 5% Urea, 125 ml SCH in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

I usually would buy XL size but in this case I bought XXL thinking since it's cotton it might shrink. But when I tried the T-shirt it was too small. My older XL sized T-shirt has 2 1/2" larger total shoulder width and 3" wider body width. See attached pictures. Length was also a bit shorter by about 1/2". I will to return it.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on April 15, 2026